PURE RED CELL APLASIA INDUCED BY ERYTHROPOIETIN
Introduction: Recombined human erythropoietin has been present in clinical practice for more than 20 years, in these therapeutic indications: anemia in kidney insufficiency, anemia during chemotherapy of tumors, prevention of anemias that appear in premature born babies, it is used for increasing au...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Association of medical doctors Sanamed Novi Pazar
2018-05-01
|
| Series: | Sanamed |
| Subjects: | |
| Online Access: | http://www.sanamed.rs/OJS/index.php/Sanamed/article/view/197/106 |